IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Webhead who wrote (461)	3/10/1997 1:53:00 PM
From: Roudy	of 1762

Hi Ed, The number in the filing of 1,105,860 is post sale. Brad has stated earlier in the thread that he thinks Smith Kline is still selling. IMO thier selling has been keeping a lid on the price, however when it breaks out it will probably be a pretty aggressive move. If this week is as good as last week in volume, we should be able to move the seller out of the way. Smith Kline could be recovering costs associated with the RA clinicals and believe they will make plenty of profits on the drug when approved. This stock just keeps getting better as time moves on. Enjoying the ride, Don

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next